Home Sunesis Pharmaceuticals, Inc. Offers A Moderate Risk 80% Return On The Short Side
 

Keywords :   


Sunesis Pharmaceuticals, Inc. Offers A Moderate Risk 80% Return On The Short Side

2014-08-22 19:40:52| Biotech - Topix.net

Sunesis Pharmaceuticals is nearing a binary event with the top-line data readout of its Phase 3 Valor trial that is expected any day now.

Tags: the return side short

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.10Eastern North Pacific Tropical Weather Outlook
05.10Atlantic Tropical Weather Outlook
05.10Weekly Recap: BASF, Beckers, Allnex, Sherwin-Williams Top This Weeks Stories
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 24
05.10Hurricane Kirk Wind Speed Probabilities Number 24
05.10Hurricane Kirk Forecast Advisory Number 24
05.10Hurricane Kirk Public Advisory Number 24
More »